Key Takeaways
- The valuation method your buyer uses largely determines the final price you receive, so you benefit from knowing the approach before you accept any offer.
- Private doctor-to-doctor buyers usually use the market approach or SDE multiples, while DSO and private equity buyers rely on normalized EBITDA multiples that can yield 40–80% higher valuations.
- Rules of thumb and “free” valuations often undervalue premier practices because they skip add-back normalization and overlook overhead efficiency, profitability, and competitive tension among buyers.
- Pressure-testing any valuation works best when you verify the method used, the documented add-backs, the normalization of EBITDA, the assumed buyer pool, and whether multiple buyers have reviewed the number.
- McLerran & Associates provides CPA-led, diligence-grade EBITDA analysis and runs a structured, auction-style bid process that often produces approximately 30% higher valuations than owners achieve selling on their own.
Schedule a free, confidential discovery call with McLerran & Associates.
How Buyers Commonly Value a Dental Practice for Sale
Dental practices are valued using three primary approaches: the income approach, the market approach, and the asset-based approach. The buyer type usually determines which approach applies. Private doctor-to-doctor buyers often value on a percentage of collections or a multiple of net cash flow. DSO and private equity buyers usually value on a multiple of EBITDA, which means earnings before interest, taxes, depreciation, and amortization, after normalizing the practice’s financials to show what it earns as a transferable business.
Top 3 Dental Practice Valuation Methods Explained
The three core approaches can produce different numbers for the same practice. Each method measures something specific and tends to align with a particular buyer type.
- Income Approach. This method values the practice on expected future earnings. For DSO and private equity deals, it usually means a multiple of adjusted EBITDA, which is the practice’s normalized operating profit after replacing the owner’s clinical production at a market-rate associate salary. For doctor-to-doctor deals, it can mean a multiple of net cash flow or seller’s discretionary earnings (SDE, which is everything the owner takes home before paying themselves a salary, including add-backs for personal and non-recurring expenses). Private buyers tend to price on SDE; DSOs price on EBITDA. This method works well for any practice with consistent, transferable cash flow. For a well-run premier practice with properly documented add-backs, it often produces the highest and most defensible number.
- Market Approach. This method values the practice against comparable sales and market benchmarks, often expressed as a percentage of annual collections. General dental practices have historically traded at roughly 65–85% of annual gross collections in private, non-DSO transactions. It fits doctor-to-doctor deals and works as a quick sanity check. It produces a useful screening number, yet it ignores overhead, profitability, and payer mix, so it can significantly undervalue a premier practice.
- Asset-Based Approach. This method values tangible assets such as equipment, furniture, and leasehold improvements, plus intangibles like goodwill. It fits distressed practices, startups, or situations with minimal cash flow. It typically produces the lowest number of the three approaches because it excludes the going-concern value of a productive patient base and trained team. Premier practices rarely benefit from this method.
The American Dental Association offers valuation guidance through its Practical Guide to Valuing a Practice and a free Practice Valuation Checklist to help dentists gather financial, statistical, and asset documents for dental practice transitions.
For a deeper look at how these methods work in real transactions, see McLerran & Associates’ overview of dental practice valuation methods explained.
How DSOs and Private Buyers Choose Valuation Methods
The buyer type, more than the method itself, often becomes the organizing principle of dental practice valuation. The same practice can be viewed very differently depending on who sits across the table.
Private doctor-to-doctor buyers typically use the market approach, such as percentage of collections, or a multiple of net cash flow or SDE. This buyer usually finances the purchase personally through an SBA-backed loan and pays close attention to cash flow and debt service. Their ceiling often reflects what the practice’s cash flow can support after debt service.
DSO and private equity buyers use the income approach, specifically a multiple of adjusted EBITDA. These buyers underwrite the practice as a transferable investment. They normalize the financials by removing owner-specific expenses and replacing the selling doctor’s clinical production at a market-rate associate salary, then apply a multiple to the remaining earnings. The same practice can produce a materially higher valuation under an EBITDA-based DSO approach than under a collections-based private-buyer approach, reflecting the 40–80% gap noted earlier.
This pattern matters because the buyer often selects the method unless the seller brings an independent analysis. An owner who accepts a rule-of-thumb or “free” number effectively hands both the method choice and the outcome to the other side of the table.
The post-COVID wave of private equity capital into the dental sector has strengthened this trend. DSO affiliation among U.S. dentists grew from 8.8% in 2017 to 16.1% in 2024, and U.S. dental recorded more than 120 private-equity add-on acquisitions in 2024, the highest volume of any healthcare-services category. More capital in the space means more buyers underwriting on EBITDA, which means more sellers benefit from understanding what that number truly reflects before they negotiate.
Find out which valuation method fits your practice.
EBITDA, SDE, and Collections: Matching Metrics to Buyers
Each metric lines up with a specific method and buyer type. A mismatch between metric and buyer pool can materially reduce your outcome.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) fits DSO and private equity deals. It requires unpacking discretionary, personal, and non-recurring expenses, a process called normalization, to show what the practice earns as a business after paying a market-rate dentist to replace the owner’s clinical production. Normalized EBITDA starts by adjusting owner-dentist compensation to a market-rate associate replacement salary. From there, it removes discretionary personal expenses and excludes one-time costs such as equipment repairs or legal settlements. The gap between reported EBITDA on a tax return and properly normalized EBITDA can be substantial, and that gap often represents value either captured or lost.
SDE (Seller’s Discretionary Earnings) often applies in doctor-to-doctor deals, especially for smaller practices where the owner’s personal production and compensation sit inside the numbers. SDE adds back the owner’s full compensation package and discretionary expenses to net income, which shows what a single owner-operator takes home. SDE applies mainly to sub-$1 million EBITDA practices acquired by private buyers, because institutional buyers separate those categories and price on EBITDA instead.
Percentage of collections functions as a market-approach rule of thumb. The American Dental Association’s guidance on buying or selling a dental practice references collections as one factor in valuing a practice’s client base, and ADA-published material notes that valuing a practice at one year’s gross revenue was once a rule of thumb but no longer applies. Current market data cited by the ADA indicate that healthy solo general practices often trade at roughly 65–85% of prior-year collections. This method remains common in doctor-to-doctor transactions. A study in Dental Economics compared 46 formal dental practice appraisals against the popular “0.8 times revenue” rule of thumb and found appraised values came in about 62% higher on average. Rules of thumb can significantly undervalue a premier practice because they do not account for normalized add-backs, overhead efficiency, or the competitive tension that a structured sale process creates.
For a detailed breakdown of the factors that influence where your practice lands within any of these ranges, see what factors determine the value of a dental practice.
EBITDA Multiples: What Drives the Range
No single fixed EBITDA multiple applies to every practice. The multiple usually falls within a range shaped by practice fundamentals, buyer demand, and market conditions, and it can shift based on which buyers participate.
The factors that can move the multiple up or down include:
- Practice size and revenue durability. Larger practices with more durable, diversified revenue tend to attract higher multiples and a broader institutional buyer pool.
- Provider independence. Practices where the selling doctor produces 90% or more of clinical revenue can see 10–20% valuation reductions because buyers model a post-close production haircut before applying any multiple.
- Payer mix. A practice deriving 60% or more of collections from in-network PPO contracts is generally viewed favorably, while heavy Medicaid exposure introduces reimbursement risk that underwriters discount.
- Hygiene mix. Practices where hygiene production accounts for 25–35% or more of total collections often achieve better offers because hygiene revenue is the most predictable and recurring component of dental EBITDA.
- Collection rate. A declining collection rate can signal a payer-mix or billing-department issue, and buyers usually price that risk into their underwriting.
- Facility and lease terms. Practices with less than three years of remaining lease term face deal risk because the landlord gains leverage. A 10-year option usually should be in place before going to market.
- Specialty demand. Certain specialties can command higher multiples than others, depending on market conditions and buyer interest.
Get a CPA-led EBITDA valuation for your practice.
How Rules of Thumb and “Free” Valuations Can Underprice Practices
Rules of thumb skip the add-back and normalization work that reveals true profitability. A collections-based percentage treats two practices identically even when one runs at 55% overhead and the other at 72%. That difference can translate to hundreds of thousands of dollars in value. Two practices each collecting $1 million can differ by roughly $300,000 in value based on overhead alone.
A “free” valuation usually functions as a lead-generation tool. The number it produces often becomes the anchor that quietly determines what the owner walks away with, simply because it is the first number on the table. A weak valuation analysis tends to collapse in due diligence, and the deal often gets re-traded down. The seller who accepted a free number at the start of the process has little independent basis to push back.
Two brokers can give two different numbers for the same practice because they may use different methods, different add-back assumptions, different buyer pools, and different levels of analytical rigor. The number carries value only when the work behind it holds up.
McLerran & Associates uses a CPA-led EBITDA analysis, which means diligence-grade work done up front, with every add-back documented and defensible before the practice goes to market. Because the homework is complete before buyers scrutinize it, the number tends to hold and the deal usually avoids re-trading. The firm has evaluated more than 10,000 dental practices and completed roughly 2,000 successful practice sales with approximately $2 billion in closed transaction volume. That depth of experience helps McLerran shape the narrative around your EBITDA rather than allowing a buyer to define it for you.
For more on why free valuations can carry hidden costs, see is a free dental practice valuation worth it?
How to Pressure-Test Any Valuation You Receive
Any valuation you receive benefits from a quick stress test before you treat it as a real offer anchor. The questions below help you understand how the number was built and how likely it is to hold up.
- Which method was used, income, market, or asset-based? The method sets the baseline, so an unstated method often signals a shallow analysis.
- What add-backs were applied, and are they documented? Undocumented add-backs are a common reason valuations fall apart during buyer due diligence.
- Is the EBITDA normalized, meaning has owner compensation been adjusted to a market-rate replacement salary? Without normalization, the figure reflects the owner’s take-home pay rather than the practice’s transferable earnings.
- What buyer pool does this number assume, private buyers, DSOs, or both? A number based on one buyer type may not translate to another.
- Is this a diligence-grade valuation or a rule-of-thumb estimate? A rule-of-thumb estimate rarely survives detailed buyer review.
- Has this number been seen by more than one buyer? A number that only one buyer has seen has not yet been tested by the market.
Several red flags can signal a valuation that deserves extra scrutiny.
- A number with no stated methodology, which makes it difficult to defend or compare.
- A valuation that only one buyer has seen, which means no competitive tension yet.
- A “free” number tied to an exclusive listing agreement, which can limit your options.
- A valuation that does not unpack discretionary expenses or document add-backs, which often understates true earnings.
Competitive tension, created by running a structured process among multiple vetted buyers, often turns a valuation into a stronger final outcome. Practices taken to market through a structured multiple-buyer solicitation process have received final transaction values averaging 50% above initial unsolicited offers. McLerran & Associates runs an auction-style bid process, typically 45–60 days and generating around 10 offers, and clients often achieve approximately 30% higher valuations on average than owners who sell on their own. That premium is the direct result of creating competition among a vetted national buyer pool.
Pressure-test your practice valuation with a sell-side advisor.
Which Method Fits Your Exit? A Summary Table
The table below maps common exit paths to the valuation method and primary metric buyers typically use, so you can quickly see which approach is likely to apply to your situation.
| Exit Path | Valuation Method | Primary Metric |
|---|---|---|
| Doctor-to-doctor walk-away sale | Market approach or income approach | Percentage of collections or SDE multiple |
| Doctor-to-doctor partnership / vest-out | Income approach | SDE or net cash flow multiple |
| DSO affiliation | Income approach | Adjusted EBITDA multiple |
| Private equity platform acquisition | Income approach | Adjusted EBITDA multiple (institutional scale) |
The method that applies to your situation can depend on your practice’s size, profitability, and the buyer pool that realistically exists for you. Because McLerran & Associates works both the private-buyer and DSO paths in roughly equal measure, it can produce a side-by-side valuation that quantifies your practice’s worth in both markets. That comparison helps you choose your path with full information rather than a guess.
Frequently Asked Questions
What Are the Top 3 Valuation Methods for a Dental Practice?
The three primary methods are the income approach, which uses a multiple of EBITDA or SDE, the market approach, which uses a percentage of annual collections, and the asset-based approach, which uses the fair market value of tangible assets plus goodwill. For many premier practices, the income approach can produce the highest and most defensible value. The market approach serves as a useful cross-check but can undervalue a well-run practice because it ignores overhead and profitability. The asset-based approach usually fits distressed or low-cash-flow practices rather than productive going concerns.
How Many Times EBITDA Is a Dental Practice Worth?
No single fixed multiple applies to every practice. The multiple usually reflects practice size, revenue durability, provider independence, payer mix, hygiene production, specialty, and which buyers are competing for the practice. Larger, more transferable practices with associate-driven production and diversified revenue often command higher multiples. Practices where the owner produces most of the revenue personally tend to receive lower multiples because buyers model post-close production risk. A competitive bid process among multiple vetted buyers can help push the multiple toward the top of the realistic range.
Why Do Two Brokers Give Different Valuations for the Same Practice?
Different methods, different add-back assumptions, different buyer pools, and different levels of analytical rigor can all produce different numbers. A broker using a collections percentage will often arrive at a different figure than one using a normalized EBITDA multiple. A broker with access to a broad, competitive buyer pool can produce a different outcome than one who knows only a few buyers. The number is only as reliable as the work and the process behind it.
Which Valuation Method Do DSOs Use vs. Private Buyers?
DSOs and private equity buyers usually use the income approach, specifically a multiple of adjusted EBITDA after normalizing the practice’s financials. Private doctor-to-doctor buyers typically use the market approach, such as percentage of collections, or a multiple of SDE or net cash flow. The same practice can produce materially different numbers under each approach, which is why buyer type often shapes dental practice valuation. Accepting a buyer’s method without independent analysis can shift control of the outcome to the buyer.
Are “Free” Valuations Reliable?
Free valuations usually function as lead-generation tools rather than diligence-grade analyses. Many of them skip the add-back and normalization work that reveals true profitability, and the number they produce often becomes the anchor for the entire negotiation. A valuation that has not been stress-tested against buyer scrutiny tends to get re-traded down during due diligence. A paid, CPA-led valuation done up front, with every add-back documented, is more likely to hold up when buyers review the details and can reduce the risk of renegotiation after you have already agreed to a price.
Conclusion and Next Steps
The buyer type often determines which valuation method gets used, and the method usually drives the number you see. Accepting a rule-of-thumb or “free” number can shift that choice to the buyer. A diligence-grade valuation that reflects true normalized profitability, paired with a process that creates competition among multiple vetted buyers, helps return that choice to the seller.
McLerran & Associates is a dental-only, sell-side advisor and advocate. It runs both the private-buyer and DSO paths in roughly equal measure, approximately a 50/50 split, which gives owners a genuine side-by-side comparison that single-lane brokers rarely provide. Every engagement starts with a CPA-led, diligence-grade EBITDA analysis and a structured, auction-style bid process among a vetted national buyer pool. The firm’s track record reflects that depth, with more than 10,000 practices evaluated, roughly 2,000 successful practice sales, and approximately $2 billion in closed transaction volume. Its transaction rate of approximately 85–90% compares with an industry norm closer to 35–40%, which shows the practical difference between a process that closes and one that stalls. Clients often achieve approximately 30% higher valuations on average than owners who sell on their own.
McLerran & Associates maintains offices across the country: Cleveland (led by Justin Klingshim), Atlanta (led by Matt Sutton), Northern Virginia (led by Andrew Kobylski), Los Angeles (led by Steven Au), and Phoenix (led by Brian Carroll, covering the Mountain West). Wherever you are, the firm brings dental-only depth and a vetted national buyer pool to your transition.
The biggest financial decision of your career can benefit from an advocate who has handled thousands of transitions and who sits on your side of the table.
Start your confidential practice valuation conversation.
